ArticleJournal of nanobiotechnology2022
A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses.
Sisi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it